Menu Search
Equities

Hogy Medical Co Ltd

3593:TYO

Hogy Medical Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)4,530.00
  • Today's Change0.00 / 0.00%
  • Shares traded38.50k
  • 1 Year change+31.88%
  • Beta0.4024
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy0
Outperform0
Hold3
Sell0
Strong Sell0

Share price forecast in JPY

The 3 analysts offering 12 month price targets for HOGY MEDICAL CO., LTD. have a median target of 3,900.00, with a high estimate of 4,450.00 and a low estimate of 3,700.00. The median estimate represents a -13.91% decrease from the last price of 4,530.00.
High-1.8%4,450.00
Med-13.9%3,900.00
Low-18.3%3,700.00

Dividends in JPY

In 2024, Hogy Medical Co Ltd reported a dividend of 80.00 JPY, which represents a 12.68% increase over last year. The 3 analysts covering the company expect dividends of 80.00 JPY for the upcoming fiscal year, maintaining dividends from this year.
Div growth (TTM)12.68%
More ▼

Earnings history & estimates in JPY

HOGY MEDICAL CO., LTD. reported annual 2024 earnings of 115.57 per share on Apr 10, 2024.
Average growth rate-8.97%
More ▼

Revenue history & estimates in JPY

of 9.73m.
Average growth rate+0.26%
Hogy Medical Co.,Ltd. had revenues for the full year 2024 of 39.10m. This was 0.31% above the prior year's results.
Average growth rate+1.27%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.